Volume 11,Issue 5
Research Progress on Treatment Strategy Selection and Long-Term Prognosis for Severe Intracranial Atherosclerotic Stenosis Undergoing Interventional Therapy
Severe intracranial atherosclerotic stenosis has a high prevalence in Asian populations and represents a major cause of ischemic stroke. Even with intensive pharmacological therapy, patients with this condition remain at substantial risk of stroke recurrence. Endovascular interventional treatment is currently the most typical supplementary therapeutic approach, primarily including balloon angioplasty, stent placement, and drug-coated balloon angioplasty. However, controversies persist in existing studies regarding the selection of the optimal strategy and long-term prognosis. This article reviews the research progress on interventional treatment modalities and long-term prognosis for this disease, so as to provide references for future related studies or clinical practice.
[1] Chimowitz MI, Lynn MJ, Howlett-Smith H, et al., 2005, Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. New England Journal of Medicine, 352(13): 1305-1316.
[2] Wang T, 2022, China angioplasty and stenting for symptomatic severe intracranial artery stenosis (CASSISS): a multicenter, randomized controlled clinical trial. National Medical Journal of China, 102(37): 2962.
[3] Zaidat OO, Fitzsimmons BF, Woodward BK, et al., 2015, Stents for the treatment of intracranial arterial stenoses: VISSIT study and acute treatment in Germany – Working paper. IQWiG.
[4] Luo JC, Wang T, Jiao LQ, 2022, Current status and future of the treatment of intracranial atherosclerotic stenosis. Medical Journal of Peking Union Medical College Hospital, 2022(6): 907-914.
[5] Bose A, Hartmann M, Henkes H, et al., 2007, A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenosis: the Wingspan Study. Stroke, 38(5): 1531-1537.
[6] Chinese Research Hospital Association, Neurointerventional Professional Committee of Chinese Medical Doctor Association, Cerebrovascular Function and Disease Branch of Chinese Neuroscience Society, 2025, Guideline for the diagnosis and treatment of intracranial atherosclerotic stenosis (2025 edition). National Medical Journal of China, 2025(29): 2449-2468.
[7] Neurointerventional Professional Committee of Chinese Medical Doctor Association, Interventional Physicians Branch of Chinese Medical Doctor Association, Neurointerventional Branch of Chinese Stroke Association, et al., 2025, Chinese expert consensus on drug coated balloon treatment for symptomatic intracranial atherosclerotic stenosis. Chinese Journal of Cerebrovascular Diseases, 2025(11): 794-804.
[8] Gao P, Wang ZF, 2023, Current status and future of interventional treatment for intracranial atherosclerotic stenosis in China. Chinese Journal of Cerebrovascular Diseases, 2023(5): 289-297.